As part of our TAG Masterclass Series we are delighted to welcome Fiona Marshall, VP Head of Discovery Research UK, MSD for an executive roundtable discussion on the development of their new Discovery Centre in London’s King’s Cross and the future of the UK investment landscape
TAG Masterclass: Long Term US Investor
Fiona Marshall, VP Head of Discovery Research UK, MSD
Fiona joined MSD in 2018 as VP Head of Discovery Research UK and has since taken on the additional role of Global Head of Neuroscience Discovery. She has more than 25 years’ experience in drug discovery and development across Pharma and Biotech companies. Previously Fiona was VP and CSO of the Japanese Biotech company Sosei Group which acquired Heptares Therapeutics in 2015. Fiona was a founder and Chief Scientific Officer of Heptares Therapeutics a highly successful UK Biotech company focussed on structure-based drug discovery. Prior to that she was European Head of Discovery Biology for Millennium Pharmaceuticals and before that held senior positions in GSK.
Fiona is on the council of the Academy of Medical sciences and on advisory boards of the Medical Research Council, the Francis Crick Institute and the Wellcome Trust. She won the 2012 WISE Women of Outstanding Achievement for Innovation and Entrepreneurship and the 2015 RSC Malcolm Campbell Award for chemistry, the 2018 John Vane medal and the 2018 Astra Zeneca Prize for Women in Pharmacology. She is a Fellow of the British Pharmacological Society and the Academy of Medical Sciences and an Honorary Fellow of the Royal Society of Chemistry.
Fiona is renowned for her work on G protein-coupled receptors (GPCRs) and has published extensively in the field. She has a BSc in biochemistry from Bath University and a PhD in neuroscience from Cambridge University.